PRIMARY2: A Phase III, Multi-Centre, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]ga-Psma-11 PET/CT in Men with Negative/equivocal MRI in the Diagnosis of Clinically Significant Prostate Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
MRI Imaging,Cancer Imaging,Prostate Cancer
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要